Colton Groome Financial Advisors, LLC Abbott Laboratories Transaction History

Colton Groome Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $192,993 - $215,035	1,915 New	1,915 $208,000
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $76,048 - $89,216	-800 Reduced 28.93%	1,965 $0
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $4,838 - $5,601	-50 Reduced 1.78%	2,765 $268,000
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $19,291 - $23,316	-189 Reduced 6.29%	2,815 $306,000
Q1 2022 Apr 18, 2022	BUY	$114.02 - $139.04 $342,516 - $417,676	3,004 New	3,004 $356,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Colton Groome Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Colton Groome Financial Advisors, LLC with notifications on news.